Founded in 2016, Eminence is committed to developing and manufacturing CHO chemically-defined media, and providing cell line and media formulation development services. Based on its proprietary formulation pool for CHO culture media, Eminence has developed EmCD CHO® basal medium and EmCD CHO® Feed for CHO-K1, CHO-S, CHO-DG44 and other cell lines. In addition, Eminence offers a wide range of tailor-made services including medium formulation development/optimization and media production to cater to individual customers' diverse needs. With an experienced R&D and production team, Eminence owns GMP-compliant medium production plants and state-of-the-art labs to provide best-of the-breed products and flexible services for customers, while helping biopharma companies comply with the increasingly stringent requirements for safety and effectiveness in the biopharma industry.